FMS

SEC filing FMS Launches EUR 1B Buyback, First Tranche EUR 600M, To Cancel Shares

5d ago

SEC filing FMS Reports 8% Organic Revenue Growth, 11.3% Operating Margin, Completes EUR 1B Share Buyback

7d ago

News Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence

14d ago

News Humacyte regains ex-U.S. rights to Symvess from Fresenius Medical Care

38d ago

SEC filing FMS Proposes EUR 1.49 Dividend, EUR 2.6B Distributable Profit, PwC Elected Auditor

49d ago

News DaVita tops chart as the only large-cap healthcare services name rated Strong Buy

84d ago

News Fresenius Medical Care Non-GAAP EPS of Є1.44, revenue of Є5.07B; introduces FY26 and long-term outlook

98d ago

News Fresenius Medical Care Q4 2025 Earnings Preview

98d ago

News DaVita climbs as Q4 beat outshines Berkshire Hathaway insider sale

118d ago

Scanner Unusual volume (3.4x average)

119d ago

News Europe Relies Too Much on China for Drugs, Fresenius CEO Warns

134d ago

News Probe Gold Announces Filing of Special Meeting Circular and Receipt of Interim Order in Respect of Proposed Plan of Arrangement with Fresnillo

155d ago

News Frankenmuth Insurance Announces Retirement of President and Chief Operating Officer and Names Successor

161d ago

News Probe Gold Announces Filing of Special Meeting Circular and Receipt of Interim Order in Respect of Proposed Plan of Arrangement with Fresnillo

167d ago

News Probe Gold Announces Filing of Special Meeting Circular and Receipt of Interim Order in Respect of Proposed Plan of Arrangement with Fresnillo

168d ago

News Probe Gold Announces Filing of Special Meeting Circular and Receipt of Interim Order in Respect of Proposed Plan of Arrangement with Fresnillo

168d ago

News Probe Gold Announces Filing of Special Meeting Circular and Receipt of Interim Order in Respect of Proposed Plan of Arrangement with Fresnillo

168d ago

News ALZpath and Siemens Healthineers Sign Licensing Agreement to Advance Global Access to Blood-Based Alzheimer's Disease Diagnostic Testing

169d ago